Title : Outpatient misoprostol compared with dinoprostone gel for preinduction cervical ripening: a randomized controlled trial.

Pub. Date : 2005 Mar

PMID : 15738009






5 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 OBJECTIVE: To determine whether a single outpatient dose of intravaginal misoprostol (versus intracervical dinoprostone gel) reduces the oxytocin use for induction. Misoprostol oxytocin/neurophysin I prepropeptide Homo sapiens
2 RESULTS: A single dose of misoprostol significantly decreased the cumulative dose of oxytocin, the cumulative time of oxytocin administration, and the dose intensity of oxytocin (dose divided by time). Misoprostol oxytocin/neurophysin I prepropeptide Homo sapiens
3 RESULTS: A single dose of misoprostol significantly decreased the cumulative dose of oxytocin, the cumulative time of oxytocin administration, and the dose intensity of oxytocin (dose divided by time). Misoprostol oxytocin/neurophysin I prepropeptide Homo sapiens
4 RESULTS: A single dose of misoprostol significantly decreased the cumulative dose of oxytocin, the cumulative time of oxytocin administration, and the dose intensity of oxytocin (dose divided by time). Misoprostol oxytocin/neurophysin I prepropeptide Homo sapiens
5 CONCLUSION: A single dose of misoprostol administered in the outpatient setting significantly decreases oxytocin use, largely due to labor within the ripening period. Misoprostol oxytocin/neurophysin I prepropeptide Homo sapiens